Your search returned 6 results.

Results
	1.	Effect of eprosartan-based therapy on systolic blood pressure and total cardiovascular risk in a large international population: preliminary report of the observational POWER study. [electronic resource] by Goudev, Assen Berrou, Jean-Pascal Pathak, Atul Producer: 20130312 In: Vascular health and risk management vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients with diabetes: results of the POWER survey. [electronic resource] by Petrella, Robert J Gill, Dawn P Berrou, Jean-Pascal Producer: 20150407 In: Diabetes, metabolic syndrome and obesity : targets and therapy vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	A novel approach to treatment of hypertension in diabetic patients - a multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 - rationale and design [ISRCTN55725285]. [electronic resource] by Pater, Cornel Bhatnagar, Deepak Berrou, Jean-Pascal Luszick, Joachim Beckmann, Katrin Publication details: Current controlled trials in cardiovascular medicine Oct 2004 In: Current controlled trials in cardiovascular medicine vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Blood pressure responses to hypertension treatment and trends in cognitive function in patients with initially difficult-to-treat hypertension: a retrospective subgroup analysis of the Observational Study on Cognitive Function and SBP Reduction (OSCAR) study. [electronic resource] by Petrella, Robert J Shlyakhto, Evgeny Konradi, Alexandra O Berrou, Jean-Pascal Sedefdjian, Armand Pathak, Atul Producer: 20120517 In: Journal of clinical hypertension (Greenwich, Conn.) vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Eprosartan-based hypertension therapy, systolic arterial blood pressure and cognitive function: analysis of Middle East data from the OSCAR study. [electronic resource] by Radaideh, Ghazi Ahmad Choueiry, Patrick Ismail, Amr Eid, Elie Berrou, Jean-Pascal Sedefdjian, Armand Sévenier, Frank Pathak, Atul Producer: 20120116 In: Vascular health and risk management vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the Observational Study on Cognitive function And Systolic Blood Pressure Reduction open-label study. [electronic resource] by Hanon, Olivier Berrou, Jean-Pascal Negre-Pages, Laurence Goch, Jan Henryk Nádházi, Zoltán Petrella, Robert Sedefdjian, Armand Sévenier, Franck Shlyakhto, Evgeny V Pathak, Atul Producer: 20080915 In: Journal of hypertension vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)